Standex International Corp/de/ Form 4 insider transactions
NYSE
Standex International Director Charles H. Cannon Jr. transferred 1,295 shares of common stock to a family trust, as reported in a Form 4 filing.
NYSE
Standex International Director Thomas E. Chorman reported selling 1,000 shares of common stock for $223.31 per share on November 20, 2025, under a Rule 10b5-1 plan.
NYSE
Standex International Director Andy L. Nemeth amended a Form 4 to correct a reported stock acquisition to an open market purchase of 1,500 shares at $205.
NYSE
Standex International Director Andy Nemeth amended a Form 4 filing to correct the transaction code for a purchase of 2,000 shares of common stock.
NYSE
Standex International's Chief HR Officer, Michelle Newbury, was granted restricted stock, phantom stock units, and restricted stock units as part of the company's incentive plan.
NYSE
Standex International's Chief Strategy Officer, Vineet Kshirsagar, reported the sale of 650 shares of common stock for approximately $233.37 per share.
NYSE
Standex International's VP/CFO/Treasurer, Ademir Sarcevic, sold 1,823 shares of common stock for approximately $230.12 per share under a pre-arranged Rule 10b5-1 plan.
NYSE
Standex International's VP, Chief HR Officer, Annemarie Bell, forfeited 111 shares of common stock to cover tax liabilities related to restricted stock vesting.
NYSE
Standex International Director Thomas E. Chorman was granted 639 shares of common stock as restricted stock, vesting in three years.
NYSE
Standex International Director Michael A. Hickey was granted 639 shares of restricted common stock, vesting in three years.
NYSE
Standex International Director Jeffrey S. Edwards was granted 639 shares of restricted common stock, vesting in three years, under the company's 2018 Omnibus Incentive Plan.
NYSE
Standex International Director Robin J Davenport received a grant of 639 shares of common stock as restricted stock, vesting in three years.
NYSE
Barbara Joanne Edwards, a Director at Standex International Corp, received a grant of 639 shares of common stock under the company's incentive plan.
NYSE
Standex International Director Andy L. Nemeth was granted 639 shares of restricted common stock, increasing his beneficial ownership to 6,639 shares.
NYSE
Standex International Director Charles H. Cannon Jr. was granted 639 shares of common stock as restricted stock, vesting in three years.
NYSE
Standex International Director Thomas J. Hansen retired, leading to the vesting of his phantom stock units into common shares.
NYSE
Standex International Corp. President, CEO, and Chairman David A. Dunbar sold 18,000 shares of common stock for $235 per share under a pre-arranged 10b5-1 trading plan.
NYSE
Standex International's VP & Chief Accounting Officer, Danielle Rangel, acquired 7 shares of common stock through an employee stock purchase plan.
NYSE
Standex International Corp's President, CEO, and Chairman, David A. Dunbar, sold 11,000 shares of common stock for $215 per share under a pre-arranged 10b5-1 trading plan.
NYSE
Standex International Corp's President, CEO, and Chairman, David A. Dunbar, transferred 17,397 shares of common stock to a revocable trust.
NYSE
Standex International's VP, Chief HR Officer, Annemarie Bell, sold 1,184 shares of common stock for $202.12 per share under a Rule 10b5-1 plan.
NYSE
Standex International Director Andy Nemeth filed a Form 4 indicating a planned acquisition of 1,500 shares of common stock at $205 per share on August 29, 2025, under a Rule 10b5-1 plan.
NYSE
Standex International's VP/CFO/Treasurer, Ademir Sarcevic, sold 1,085 shares of common stock for approximately $209.86 per share on August 26, 2025, under a Rule 10b5-1 plan.
NYSE
Standex International's VP & Chief Accounting Officer, Danielle Rangel, reported the vesting of restricted stock units, tax-related share sales, and new equity awards.
NYSE
Standex International Corp's CLO, VP & Secretary, Alan J. Glass, reported multiple acquisitions of common stock through vesting and subsequent sales for tax obligations, alongside new equity awards.
NYSE
Annemarie Bell, VP and Chief HR Officer at Standex International, reported vesting of equity awards and subsequent tax-related share sales.
NYSE
Standex International's President, CEO, and Chairman, David A. Dunbar, reported the vesting of various equity awards and subsequent tax-related share dispositions, alongside new equity grants.
NYSE
Standex International's CFO, Ademir Sarcevic, reported scheduled vesting of equity awards and subsequent tax-related stock sales, alongside new performance and restricted stock unit grants.
NYSE
Standex International's VP and CIO, Max Arets, reported the vesting of restricted stock units, a tax-related share sale, and new equity awards.
NYSE
Standex International Director Barbara Joanne Edwards acquired 387 shares of common stock through the vesting of phantom stock units and received a new grant of 209 phantom stock units.